Instead, the very favorable effects of ICB in HL have largely been attributed to the expression of HLA‐II and thus to activation of CD4+ T cells as well as to early T‐cell independent effects on the TME such as reverse signaling or T‐cell activity without proliferation.5, 6, 11, 19, 41. The gene discussed is CD4; the disease is Hodgkins lymphoma.